Business Wire

Bureau Veritas Strengthens Its Leading Position in the Chilean Copper Market Through the Acquisition of GeoAssay

Share

Bureau Veritas, a global leader in Testing, Inspection, and Certification services (TIC), announces the acquisition of GeoAssay. This transaction cements Bureau Veritas’ position as the Metals & Minerals market leader in Chile, the world’s largest copper producer.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250316180459/en/

Hinda Gharbi, Chief Executive Officer at Bureau Veritas

Bureau Veritas’ Metals & Minerals operations aim to support our clients throughout the entire mining cycle, from mine to port. This is achieved by accurately determining the physical, chemical and geochemical properties of materials through our extensive network of laboratories. With a global presence in major ports around the world and with global mining and refining locations, Bureau Veritas’ footprint is expanding in this resource-rich region.

GeoAssay specializes in copper, an essential mineral for energy transition at scale. Capabilities include mechanical preparation and analysis of minerals samples. The company operates three state-of-the-art laboratories in Chile. These facilities are fully automated and strategically located providing the Group with a significant presence and increased customer proximity in the region. The company operates with 264 technical employees with deep knowledge in robotics, automation, and with mining industry backgrounds.

With this acquisition, Bureau Veritas will offer enhanced services in the copper segment to existing clients and will also attract new customers who require precision, high accuracy, full traceability and rapid-turnaround time for mineral analysis.

This acquisition positions Bureau Veritas at the forefront of mineral testing activities in this essential copper market of Chile. This is fully aligned with our LEAP | 28 strategy, said Hinda Gharbi, Chief Executive Officer of Bureau Veritas.The integration of GeoAssay’s state-of-the-art laboratories allows us to immediately meet growing customer demands in Latin America. Our clients will benefit from faster and more accurate results, further strengthening our position in this market. I would like to welcome our new colleagues to Bureau Veritas.”

Feliciano Herrera – Chief Executive Officer of GeoAssay, added,“I am thrilled about this transaction. Our investments since 2017 are now bearing fruit and I am confident that our laboratory testing activities will reach new heights by leveraging Bureau Veritas’ expertise and scale. Beyond our cutting-edge industrial facilities, the expertise of our 264 employees will bring indisputable added value to Bureau Veritas’ extensive customer portfolio.”

About Bureau Veritas

Bureau Veritas is a world leader in inspection, certification, and laboratory testing services with a powerful purpose: to shape a world of trust by ensuring responsible progress. With a vision to be the preferred partner for customers’ excellence and sustainability, the company innovates to help them navigate change.

Created in 1828, Bureau Veritas’ 84,000 employees deliver services in 140 countries. The company’s technical experts support customers to address challenges in quality, health and safety, environmental protection, and sustainability.

Bureau Veritas is listed on Euronext Paris and belongs to the CAC 40, CAC 40 ESG, SBF 120 indices and is part of the CAC SBT 1.5° index. Compartment A, ISIN code FR 0006174348, stock symbol: BVI.

For more information, visit http://www.bureauveritas.com, and follow us on LinkedIn.

Our information is certified with blockchain technology.
Check that this press release is genuine at www.wiztrust.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250316180459/en/

Contacts

ANALYST/INVESTOR CONTACTS

Laurent Brunelle
+33 (0)1 55 24 76 09
laurent.brunelle@bureauveritas.com

Colin Verbrugghe
+33 (0)1 55 24 77 80
colin.verbrugghe@bureauveritas.com

Karine Ansart
karine.ansart@bureauveritas.com

Inès Lagoutte
ines.lagoutte@bureauveritas.com

MEDIA CONTACTS

Anette Rey
+33 (0)6 69 79 84 88
anette.rey@bureauveritas.com

Martin Bovo
+33 (0) 6 14 46 79 94
martin.bovo@bureauveritas.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

www.businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Brisbane Airport embraces advanced analytics from Cirium Sky Warehouse18.3.2025 00:00:00 EET | Press release

Brisbane Airport (BNE), which serves as the major gateway to Queensland, has partnered with aviation analytics firm, Cirium, to become one of the first airports to integrate Cirium Sky Warehouse, a data-driven cloud platform, into its modernisation efforts. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250317052819/en/ Brisbane Airport Cirium’s advanced data and analytics will be seamlessly integrated with Brisbane Airport’s business systems. This integration will support enhanced capacity planning, resource allocation, and operations analysis. Jeremy Bowen, Cirium CEO, commented: "We are delighted to support Brisbane Airport’s transformative investment to revolutionise its passenger experience and meet future travel demand. “Integrating Cirium data and analytics through the Cirium Sky Warehouse will help the airport to consolidate and accelerate digitization, leading to improved decision-making and operational performance.

Trump-Inspired World Liberty Financial Closes $550 Million Across Token Sales17.3.2025 21:37:00 EET | Press release

World Liberty Financial, Inc. (“WLFI”), the developer of a pioneering DeFi protocol and governance platform inspired by Donald J. Trump, has made history with the completion of the second set of its token sales, totaling $550 million in gross proceeds in concurrent U.S. and non-U.S. token offerings. After launching on October 15, 2024, WLFI has successfully concluded two sets of token sales in concurrent U.S. and non-U.S. offerings. In the first set, $300 million USD of WLFI tokens were sold between the offerings, and in the second set, $250 million USD of WLFI tokens were sold between the offerings. Between all the offerings, $550 million USD in WLFI tokens have been sold. More than 85,000 total participants in the token sales underwent Know Your Customer (KYC) process to determine participation eligibility. "This milestone proves that those who truly understand crypto and finance recognize what we’re building — and that WLFI is on track to supercharge DeFi as it transforms global fin

RevBio Initiates its Pivotal Clinical Trial in Europe for its Dental Implant Stabilization Product17.3.2025 21:28:00 EET | Press release

RevBio, Inc., announced that it has received regulatory and ethics committee approvals in multiple European countries to conduct its pivotal clinical trial for its dental implant stabilization product. The successful completion of this pivotal clinical trial will result in the CE marking approval for the product, which will allow the company to begin commercial sales in Europe. As of the date of this press release, the company has already enrolled 30 of an expected 75 patients in this clinical trial. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250306978603/en/ RevBio initiates a pivotal clinical trial in Europe for its Dental Implant Stabilization product with 30 of 75 expected patient enrollments. Clinical Images courtesy of Prof. France Lambert of the University of Liege. “The results from this ongoing international multicenter study are exceeding expectations, showcasing remarkable outcomes. We are profoundly optimisti

Egle Therapeutics Receives €9.3 Million in State Funding Under the “Innovations in Biotherapies and Bioproduction” Call for Projects from France 203017.3.2025 20:00:00 EET | Press release

Egle Therapeutics, a clinical-stage biotechnology company developing therapies targeting regulatory T cells (Tregs) for immuno-oncology and autoimmune diseases, today announced that it has secured €9.3 million in state funding under the “Innovations in Biotherapies and Bioproduction” call for projects from the France 2030 plan, managed on behalf of the French government by Bpifrance. Founded in 2020 as a spin-off from Institut Curie, Egle Therapeutics is a clinical-stage biotechnology company specializing in immunomodulation, with the ambition to develop novel approaches to the modulation of Treg activity for the treatment of cancer and autoimmune diseases. Egle Therapeutics has developed a proprietary translational platform to identify novel tumor-infiltrating Treg targets, with the aim of developing antibody-based candidate drugs to disable Treg function and restore an effective antitumor immune response. In June 2020, Egle Therapeutics entered a strategic partnership with Takeda Pha

The World Celebrates Ireland This St Patrick’s Day17.3.2025 17:19:00 EET | Press release

People around the world revelled in all things Irish on 17th March – the annual global celebration of Irish culture, arts and heritage known as St Patrick’s Day. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250317647496/en/ In Dublin, around half a million people lined the streets of the capital for the St Patrick’s Festival parade, which this year has the theme of ‘Adventures’ – or ‘Eachtraí’ in Irish – representing the legendary adventurous Irish spirit, loved the world over. St Patrick's Day is marked all over the world by the 70 million who claim links to Ireland. Celebrating Ireland’s national colour, the defining natural green lands, the Global Greenings returned for St Patrick’s Day, with iconic international landmarks lighting up in green including Niagara Falls, the Leaning Tower of Pisa, the Empire State Building, the Sky Tower in Auckland, the Royal Liver Building in Liverpool, the Sacré-Cœur in Paris, as well a

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye